The short answer
Panax ginseng’s glucose effects vary, and an increased hypoglycemia risk with regular human insulin has not been established. Species and extract differences are important.
What this answer covers
Asian Panax ginseng, including specific root-extract studies; American ginseng is a separate species.
- Supplement or preparation
- Panax ginseng
- Medication ingredient
- insulin, regular, human
Some findings were null or opposite
Two acute studies of Asian ginseng found no overall improvement in glucose or insulin responses, with a higher two-hour glucose measure in pooled treatment. Results cannot simply be borrowed from American ginseng.
A particular extract showed benefit
A short vinegar-extracted-ginseng study reported improved HbA1c in drug-naive diabetes patients. It did not test regular human insulin, so it cannot measure combination hypoglycemia.
One product cannot represent all ginseng
Processing and constituent content change the exposure. The contrasting studies do not establish a safe glulisine combination dose or show that every ginseng product lowers glucose.
No ginseng requirement follows
These studies do not show that regular insulin creates a need for ginseng or establish a protective spacing interval. Discuss product changes with the diabetes team and follow your glucose-monitoring plan.
Evidence and practical considerations
Timing & monitoring
No established supplement requirement or protective spacing interval with regular human insulin; glucose monitoring does not demonstrate a nutrient need.
- Exact scope
- Asian Panax ginseng, including specific root-extract studies; American ginseng is a separate species. with Regular human insulin RxCUI253182 IN; U100/U500 and routes distinct.
- Medication form and route
- injected regular human insulin; oral supplement
What remains uncertain
- No exact herb-event rate or arbitrary insulin change.
Factors that may matter: Concentration; Route; Meals; Product; Other diabetes treatment.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed regular human insulin
Hypoglycemia can be severe. Niacin may decrease glucose lowering. Treatment changes can require increased monitoring and clinician review. Subcutaneous dose given30minutes before meals.
How this applies: Exact RxCUI253182 IN regular human insulin; U100/U500 distinguished from NPH and rapid analogs.
Product concentration, devices, route and action profile matter. No supplement-specific adverse-event incidence.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed regular human insulin
Hypoglycemia can be severe. Niacin may decrease glucose lowering. Treatment changes can require increased monitoring and clinician review. Subcutaneous dose given30minutes before meals. Concentration gives a different time course with both prandial and basal activity.
How this applies: Exact RxCUI253182 IN regular human insulin; U100/U500 distinguished from NPH and rapid analogs.
Product concentration, devices, route and action profile matter. No supplement-specific adverse-event incidence.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Two groups of11healthy volunteers.
No significant overall glucose/insulin effect; pooled Asian-ginseng treatment had higher two-hour glucose than placebo.
How this applies: Indirect for exact regular human insulin; source drug, preparation and endpoint retained.
Small healthy-volunteer studies; not regular-insulin co-use. Contradicts automatic transfer of American-ginseng results to Panax ginseng. This does not establish an exact regular-human-insulin interaction.
Source 4: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 72drug-naive adults with type 2 diabetes.
Vinegar-extracted Panax ginseng improved HbA1c in a small trial, with no severe adverse events reported in the abstract.
How this applies: Indirect for exact regular human insulin; source drug, preparation and endpoint retained.
Drug-naive patients; not glipizide. Specialized extract not interchangeable with all root products. This does not establish an exact regular-human-insulin interaction.
Research assessment: · Open full citations ↗
Side effects & toxicity
Indirect preparation-specific clinical evidence does not establish added hypoglycemia with regular human insulin.
- Exact scope
- Asian Panax ginseng, including specific root-extract studies; American ginseng is a separate species. with Regular human insulin RxCUI253182 IN; U100/U500 and routes distinct.
- Medication form and route
- injected regular human insulin; oral supplement
What remains uncertain
- No exact herb-event rate or arbitrary insulin change.
Factors that may matter: Concentration; Route; Meals; Product; Other diabetes treatment.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed regular human insulin
Hypoglycemia can be severe. Niacin may decrease glucose lowering. Treatment changes can require increased monitoring and clinician review. Subcutaneous dose given30minutes before meals.
How this applies: Exact RxCUI253182 IN regular human insulin; U100/U500 distinguished from NPH and rapid analogs.
Product concentration, devices, route and action profile matter. No supplement-specific adverse-event incidence.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed regular human insulin
Hypoglycemia can be severe. Niacin may decrease glucose lowering. Treatment changes can require increased monitoring and clinician review. Subcutaneous dose given30minutes before meals. Concentration gives a different time course with both prandial and basal activity.
How this applies: Exact RxCUI253182 IN regular human insulin; U100/U500 distinguished from NPH and rapid analogs.
Product concentration, devices, route and action profile matter. No supplement-specific adverse-event incidence.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Two groups of11healthy volunteers.
No significant overall glucose/insulin effect; pooled Asian-ginseng treatment had higher two-hour glucose than placebo.
How this applies: Indirect for exact regular human insulin; source drug, preparation and endpoint retained.
Small healthy-volunteer studies; not regular-insulin co-use. Contradicts automatic transfer of American-ginseng results to Panax ginseng. This does not establish an exact regular-human-insulin interaction.
Source 4: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 72drug-naive adults with type 2 diabetes.
Vinegar-extracted Panax ginseng improved HbA1c in a small trial, with no severe adverse events reported in the abstract.
How this applies: Indirect for exact regular human insulin; source drug, preparation and endpoint retained.
Drug-naive patients; not glipizide. Specialized extract not interchangeable with all root products. This does not establish an exact regular-human-insulin interaction.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact regular-insulin article with route, concentration and clinical endpoint boundaries. | |
| Research summary published |
Article revision: 3a63b989a33b4a23
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.